Molecular Pharmacology (USA) Ltd. is a shell company. The company is headquartered in Leederville, Western Australia. The company went IPO on 2005-05-20. The firm is not engaged in any business activities.
How did MLPH's recent EPS compare to expectations?
The most recent EPS for Molecular Pharmacology (USA) Ltd is $, expectations of $.
How did Molecular Pharmacology (USA) Ltd MLPH's revenue perform in the last quarter?
Molecular Pharmacology (USA) Ltd revenue for the last quarter is $
What is the revenue estimate for Molecular Pharmacology (USA) Ltd?
According to of Wall street analyst, the revenue estimate of Molecular Pharmacology (USA) Ltd range from $ to $
What's the earning quality score for Molecular Pharmacology (USA) Ltd?
Molecular Pharmacology (USA) Ltd has a earning quality score of B-/23.174143. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does Molecular Pharmacology (USA) Ltd report earnings?
Molecular Pharmacology (USA) Ltd next earnings report is expected in
What are Molecular Pharmacology (USA) Ltd's expected earnings?
Molecular Pharmacology (USA) Ltd expected earnings is $, according to wall-street analysts.
Did Molecular Pharmacology (USA) Ltd beat earnings expectations?
Molecular Pharmacology (USA) Ltd recent earnings of $ expectations.